Edwards Lifesciences Rest of World — Total other segment items decreased by 63.0% to -$7.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 18.5%, from -$9.20M to -$7.50M. Over 3 years (FY 2022 to FY 2025), Rest of World — Total other segment items shows a downward trend with a 140.4% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Large fluctuations often indicate non-recurring events like restructuring or one-time charges, which can obscure the underlying operational performance of the segment.
This metric aggregates miscellaneous income or expense items specifically attributed to the Rest of World segment that a...
Comparable to 'Other Segment Charges' or 'Unallocated Segment Expenses' found in the segment reporting notes of peer companies.
ew_segment_rest_of_world_total_other_segment_items| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$475.00K | -$475.00K | -$475.00K | -$475.00K | -$125.00K | -$125.00K | -$125.00K | -$125.00K | -$1.10M | -$3.00M | -$2.70M | -$3.70M | -$9.20M | -$7.90M | -$4.70M | -$4.60M | -$7.50M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +73.7% | +0.0% | +0.0% | +0.0% | -780.0% | -172.7% | +10.0% | -37.0% | -148.6% | +14.1% | +40.5% | +2.1% | -63.0% |
| YoY Change | — | — | — | — | +73.7% | +73.7% | +73.7% | +73.7% | -780.0% | <-999% | <-999% | <-999% | -736.4% | -163.3% | -74.1% | -24.3% | +18.5% |